We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-3.85%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$140B
AUM Growth
+$5.37B
Cap. Flow
+$13.5B
Cap. Flow %
9.64%
Top 10 Hldgs %
30.28%
Holding
6,714
New
321
Increased
2,151
Reduced
2,607
Closed
759

Sector Composition

Rank Sector Weight
1 Technology 8.94%
2 Healthcare 5.53%
3 Financials 5.03%
4 Consumer Discretionary 4.6%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFSW
5376
DELISTED
PFSweb, Inc.
PFSW
$2K ﹤0.01%
256
-782
-75% -$8.06K
AC
5377
DELISTED
Associated Capital Group
AC
$1K ﹤0.01%
27
-100
-79% -$3.92K
ACB
5378
Aurora Cannabis
ACB
$168M
$1K ﹤0.01%
110
-1,959
-95% -$28.8K
ADVM
5379
DELISTED
Adverum Biotechnologies
ADVM
$1K ﹤0.01%
119
-122
-51% -$1.6K
AIRS icon
5380
AirSculpt Technologies
AIRS
$329M
$1K ﹤0.01%
189
-558
-75% -$4.48K
ALGS icon
5381
Aligos Therapeutics
ALGS
$26.3M
$1K ﹤0.01%
23
-41
-64% -$1.36K
ASM
5382
Avino Silver & Gold Mines
ASM
$964M
$1K ﹤0.01%
2,800
-17,500
-86% -$9.84K
ASPS icon
5383
Altisource Portfolio Solutions
ASPS
$58.1M
$1K ﹤0.01%
13
-62
-83% -$5.75K
BDTX icon
5384
Black Diamond Therapeutics
BDTX
$101M
$1K ﹤0.01%
573
-481
-46% -$1.48K
BH icon
5385
Biglari Holdings Class B
BH
$1.18B
$1K ﹤0.01%
12
-50
-81% -$6.26K
BOLT icon
5386
Bolt Biotherapeutics
BOLT
$7.72M
$1K ﹤0.01%
25
-18
-42% -$745
BRLT icon
5387
Brilliant Earth
BRLT
$18.4M
$1K ﹤0.01%
+156
New +$1.01K
CADL icon
5388
Candel Therapeutics
CADL
$709M
$1K ﹤0.01%
335
-95
-22% -$322
CARM
5389
DELISTED
Carisma Therapeutics
CARM
$1K ﹤0.01%
130
-132
-50% -$1.8K
CLLS
5390
Cellectis
CLLS
$286M
$1K ﹤0.01%
253
-71
-22% -$215
CLPR
5391
Clipper Realty
CLPR
$46.5M
$1K ﹤0.01%
184
-834
-82% -$6.98K
CLSD
5392
DELISTED
Clearside Biomedical
CLSD
$1K ﹤0.01%
48
-13
-21% -$285
GPGI
5393
GPGI Inc
GPGI
$4.23B
$1K ﹤0.01%
144
-385
-73% -$1.8K
CPSS icon
5394
Consumer Portfolio Services
CPSS
$207M
$1K ﹤0.01%
147
-752
-84% -$8.63K
CRD.A icon
5395
Crawford & Co Class A
CRD.A
$551M
$1K ﹤0.01%
236
-215,893
-100% -$1.44M
CRIS icon
5396
Curis
CRIS
$9.41M
$1K ﹤0.01%
3
-3
-50% -$1.21K
CTMX icon
5397
CytomX Therapeutics
CTMX
$701M
$1K ﹤0.01%
795
-882
-53% -$1.36K
CURV icon
5398
Torrid Holdings
CURV
$271M
$1K ﹤0.01%
227
-77,356
-100% -$405K
DES icon
5399
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
$1K ﹤0.01%
55
-29
-35% -$840
DMLP icon
5400
Dorchester Minerals
DMLP
$1.3B
$1K ﹤0.01%
60

Similar funds

Citigroup's Q3 2022 Portfolio in Review

As of Q3 2022, Citigroup held 6,714 positions worth $140B, up 4% from $134B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citigroup deployed $13.5B of net new capital in Q3 2022, opening 321 new positions and adding to 2,151 existing holdings. Its largest new stake was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.31B trimmed.

  • Citigroup's largest Q3 2022 buy was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
  • Citigroup added most to Lowe's Companies in Q3 2022, an estimated $539M increase.
  • Citigroup's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.31B.
  • Citigroup fully exited GCP Applied Technologies Inc. in Q3 2022, selling an estimated $18.7M.
  • Citigroup's ten largest holdings make up 30% of its $140B portfolio in Q3 2022.
  • Citigroup opened 321 new positions and closed 759 in Q3 2022.
  • Citigroup's portfolio value rose 4% quarter-over-quarter to $140B.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.